Kyverna Therapeutics, Inc. (Nasdaq: KYTX) ('Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell ...
A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...
No one has yet created a fully functioning artificial cell. But a research team at Aarhus University has taken a step in that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback